Loryna is a low-dose birth control pill. Each active tablet contains 0.02 mg (20 micrograms) of ethinyl estradiol, which places it at the lower end of the low-dose category. Combined oral contraceptives with less than 50 micrograms of ethinyl estradiol are classified as low-dose, and Loryna sits well below that threshold. Some providers and patients even consider 20-microgram pills to be “ultra-low-dose,” since most standard low-dose pills contain 30 to 35 micrograms.
What’s in Each Loryna Tablet
Each pack of Loryna contains 24 active peach tablets and 4 inactive white tablets. The active tablets each deliver 3 mg of drospirenone (the progestin) and 0.02 mg of ethinyl estradiol (the estrogen). Loryna is a generic version of Yaz, and the two contain identical hormone types and amounts. Other generics with the same formulation include Gianvi, Nikki, and Ocella.
Drospirenone is a newer type of progestin that isn’t derived from testosterone, which sets it apart from older progestins like levonorgestrel and norethindrone. It has mild anti-androgenic properties, meaning it works against the hormones that contribute to oily skin and acne. It also has a mild diuretic effect similar to spironolactone, which can reduce water retention and bloating that some people experience on other pills.
How It Compares to Other Pills
Most “regular” low-dose pills on the market contain 30 to 35 micrograms of ethinyl estradiol. Loryna’s 20 micrograms puts it a step below those. A handful of pills go even lower: some formulations contain just 10 micrograms of ethinyl estradiol and are sometimes labeled ultra-low-dose. So Loryna sits in a middle ground, lower than the most commonly prescribed pills but not the absolute minimum estrogen available.
The lower estrogen content generally means fewer estrogen-related side effects like breast tenderness, nausea, and headaches. The trade-off is that very low estrogen pills can sometimes cause more breakthrough bleeding, especially in the first few months. Most people find this settles after two to three cycles as the body adjusts.
The 24/4 Schedule
Loryna uses a 24/4 regimen: 24 days of active hormone pills followed by 4 days of inactive pills. This is shorter than the traditional 21/7 schedule found in older pills, where you take hormones for 21 days and then have 7 hormone-free days. The shorter break means your hormone levels stay more stable throughout the month, which is one reason this formulation works well for premenstrual symptoms. It also helps suppress ovulation more consistently. Your withdrawal bleed during the 4 inactive days tends to be lighter and shorter than what you’d experience with a 21/7 pill.
FDA-Approved Uses Beyond Contraception
Loryna is approved for three purposes: preventing pregnancy, treating premenstrual dysphoric disorder (PMDD), and treating moderate acne in people 14 and older. The PMDD and acne approvals are specifically tied to people who also want contraception, meaning the pill isn’t intended as a standalone acne or mood treatment for someone who doesn’t need birth control.
The acne benefit comes from drospirenone’s anti-androgenic effect. By lowering the activity of androgens in your body, it reduces the excess oil production that clogs pores. For PMDD, the 24/4 dosing schedule plays a key role. The shorter hormone-free interval keeps hormone fluctuations smaller, which helps stabilize the mood swings, irritability, and physical symptoms that define PMDD.
Blood Clot Risk With Drospirenone
All combined birth control pills carry a small risk of blood clots, but the type of progestin matters. A large study using UK medical records found that drospirenone-containing pills were associated with roughly 23 blood clot events per 100,000 women per year, compared to about 9 per 100,000 for pills containing levonorgestrel, an older progestin. That translates to roughly a threefold higher relative risk with drospirenone.
In absolute terms, both numbers are small. For context, the risk of blood clots during pregnancy is significantly higher than with any oral contraceptive. But if you have additional risk factors for clots, such as smoking, a history of blood clots, obesity, or a clotting disorder, this difference is worth discussing with your provider. The lower estrogen in Loryna helps somewhat, since estrogen is the main driver of clot risk, but it doesn’t eliminate the progestin-related difference entirely.
Potassium and the Diuretic Effect
Because drospirenone acts like a mild potassium-sparing diuretic, there were early concerns that it could raise potassium levels to a dangerous degree. A post-marketing study requested by the FDA found this fear was largely unfounded for most people. Women starting drospirenone-containing pills had no higher rate of elevated potassium or related complications than women on other oral contraceptives.
That said, this effect becomes relevant if you’re taking other medications that also raise potassium, such as certain blood pressure drugs (ACE inhibitors, ARBs), potassium-sparing diuretics, or potassium supplements. In those cases, your provider may want to check your potassium levels during the first month.
Common Side Effects
Because Loryna is on the lower end of estrogen dosing, many people tolerate it well. The most commonly reported side effects include headaches, nausea, breast tenderness, and mood changes, particularly in the first one to three months. Some people experience spotting or irregular bleeding early on, which is more common with lower-estrogen formulations but usually resolves.
The drospirenone component can cause a mild reduction in water weight, which is why some people feel less bloated on Loryna compared to pills with older progestins. This isn’t significant weight loss, just less fluid retention. On the flip side, some people report decreased libido or changes in mood, though these vary widely from person to person.